HealthTree Podcast for Multiple Myeloma

HealthTree Podcast for MM
  • ٤٫٩ (١٨)
  • الصحة واللياقة

HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.

  1. قبل ٥ أيام

    2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

    The world of immunotherapy in multiple myeloma is exploding - with new treatments being FDA-approved and others working their way through the FDA approval process. In this show, Dr. Paul Richardson focuses on the innovation in immunotherapy that we've seen in the first half of 2025. This includes a discussion about CAR T, bispecific and trispecific antibodies, and a deeper dive on a new class of drugs in myeloma called Antibody Drug Conjugates, with a drug called belantamab mafodotin going through the FDA review process, with a hopeful approval in October of this year.

    ٣٠ من الدقائق

  2. قبل ٥ أيام

    2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

    Multiple myeloma treatment is advancing in promising ways. Learn about mid-year updates in multiple myeloma from the ASCO and EHA conferences and what to expect from the upcoming International Myeloma Society (IMS) meeting with Paul Richardson, MD, Dana Farber Cancer Institute.

    ٣٠ من الدقائق

  3. ٤ أبريل

    Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

    Learn more about Minimal Residual Disease (MRD) testing and how it’s being used today in research and for your myeloma care. Join Rafael Fonseca, MD, Mayo Clinic to learn when MRD testing should be done and how the results should be used in myeloma care

    ١ من الساعات

  4. ٣ مارس

    Preventing Myeloma Progression with Diet: The Nutrivention-2 Stu

    Through her extensive (and continuing) research, Dr. Urvi Shah, a multiple myeloma specialist at Memorial Sloan Kettering Cancer Center, is determined to find answers to the often-asked question by patients with precursor myeloma conditions, “What diet is best for me?” l Can a plant based diet affect your overall health? Can it affect your blood cancer progression or time to relapse? What does the science say about it, and what questions still need to be answered? Join us to discuss these topics and answer these questions and more.  HealthTree is working with Dr. Urvi Shah's team at MSK in "Nutrivention-2", a national, multi-arm, randomized prospective telehealth study for MGUS and smoldering myeloma patients. This study will explore the microbial changes in response to a plant-based diet and supplements in smoldering myeloma patients. You can learn more about it HERE. If you're interested and want more information, please contact our support team - support@healthtree.org.

    ٤٨ من الدقائق

  5. ١٢ فبراير

    The Future of Bispecific Antibodies with Dr. Philippe Moreau

    Bispecific antibodies are a growing class of treatment in multiple myeloma. Learn from global expert and International Myeloma Society (IMS) President Dr. Philippe Moreau about the advances being made in bispecific antibodies and what clinicians are learning about how and when to best use this therapy. Dr. Moreau will provide a review of approved and in-development bispecific antibodies, side effect management and more. Learn how HealthTree and IMS are partnering on the HealthTree Bispecific Antibody Study to provide more data and patient experiences to help the research community come to faster conclusions about this new, exciting treatment.

    ٥٧ من الدقائق

  6. ١ فبراير

    A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

    Learn about what's here and what's coming in 2025 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

    ٥٨ من الدقائق

  7. ٣١‏/١٢‏/٢٠٢٤

    Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of Minnesota

    New discoveries in multiple myeloma are made possible through a deep understanding of the disease. Many researchers contribute significantly to these breakthroughs by performing essential lab work, often without ever treating patients directly. In this episode, we’re joined by Dr. Brian Van Ness, a PhD researcher from the University of Minnesota who has dedicated decades to studying the biology and genetics of multiple myeloma. Dr. Van Ness shares how his lab research has laid the foundation for new insights into this complex disease and how his unwavering love for patients has driven his work during his extensive career. Tune in to learn how cutting-edge research translates into better outcomes for the myeloma community and how researchers like Dr. Van Ness are shaping the future of care.

    ١ س ١١ د

  8. ٠٧‏/١١‏/٢٠٢٤

    2024 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

    Learn about the latest in multiple myeloma advances with Paul Richardson, MD who will cover the recent American Society of Hematology and European Hematology Association meeting findings.

    ١ س ١٠ د
مشاهدة الكل (١٧٨)

٤٫٩
من ٥
‫١٨ من التقييمات‬

حول

HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.

المعلومات

  • صناع العمل
    HealthTree Podcast for MM
  • سنوات النشاط
    ٢٠١٣ - ٢٠٢٥
  • الحلقات
    ١٧٨
  • التقييم
    ملائم
  • حقوق النشر
    © HealthTree Podcast for MM
  • موقع البرنامج على الويب
    HealthTree Podcast for Multiple Myeloma

قد يعجبك أيضًا